Products

• Unique technology: Parry Nutraceuticals employs novel technology and processes in cultivation and production, to ensure stability and purity of Parry’s Natural Astaxanthin. Parry Nutraceuticals has a patent to this effect.
• The algal facility is located at Oonaiyur, an isolated hamlet in southern India away from industrial pollution, ground water contamination and with a conducive environment for growth of the algae.
• Grown in an algal facility certified ISO 9001, ISO 14001 and HACCP. Parry's Natural Astaxanthin is KOSHER and HALAL certified.
• Parry Nutraceuticals offers a stable Haematococcus pluvialis biomass with a concentration of 15,000 PPM of astaxanthin.
• Parry Nutraceuticals also offers astaxanthin oleoresins (solvent extracted) 2.5% and 5%, ideal for softgel formulations. We also offer a microencapsulated powder (1.5% DC grade) to suit various formulation requirements like capsules and tablets.
• Parry Nutraceuticals has an alliance with Valensa International. Valensa International in the US has a patent for astaxanthin in eye care – Zanthin ® patent no:  5,527,533, which shows that astaxanthin plays an important role in reducing macular degeneration, and damage caused by UV radiation.  
• Through Valensa, Parry can also offer Co2 extracted Zanthin® oleoresins (7%), beadlets (2.5%) and zanthin® soft gels with a delivery of 4 mg Astaxanthin.
• Valensa has a unique trade marked supercritical CO2 extraction process called Deep Extract ™. They also use a stabilization technology called O2B™ to add more stability to this sensitive product.

Hence, Parry’s Astaxanthin is a preferred product in varied applications such as dietary supplements, functional beverages, cosmetics and high quality animal feed & pet food formulations.